Russia and Ukraine are poised to hold a second round of talks in Abu Dhabi on February 4-5; the New START arms control treaty between the US and Russia expires on February 4 with no extension agreed; ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

The International AI Safety Report 2026 has been released today on 3 February 2026, marking the second iteration of the most comprehensive global assessment of artificial intelligence capabilities, ...

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo ...

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Th ...

Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's ...

Hide your strength and bide your time,” Deng Xiaoping, the transformative Chinese premier, once advised – a maxim that became ...

Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...

Vitalik Buterin Proposes Fix For Content-Creator Coin Model. Ethereum co-founder Vitalik Buterin has proposed a novel creator ...

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positiv ...

Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...